Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A proteomics approach to the identification of biomarkers for psoriasis utilising keratome biopsy.

Williamson JC, Scheipers P, Schwämmle V, Zibert JR, Beck HC, Jensen ON.

J Proteomics. 2013 Dec 6;94:176-85. doi: 10.1016/j.jprot.2013.09.010. Epub 2013 Sep 20.

PMID:
24061002
2.

Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.

Harel M, Oren-Giladi P, Kaidar-Person O, Shaked Y, Geiger T.

Mol Cell Proteomics. 2015 Apr;14(4):1127-36. doi: 10.1074/mcp.M114.043364. Epub 2015 Jan 26.

3.

Biomarkers of An Autoimmune Skin Disease--Psoriasis.

Jiang S, Hinchliffe TE, Wu T.

Genomics Proteomics Bioinformatics. 2015 Aug;13(4):224-33. doi: 10.1016/j.gpb.2015.04.002. Epub 2015 Sep 8. Review.

4.

Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans.

Lundberg KC, Fritz Y, Johnston A, Foster AM, Baliwag J, Gudjonsson JE, Schlatzer D, Gokulrangan G, McCormick TS, Chance MR, Ward NL.

Mol Cell Proteomics. 2015 Jan;14(1):109-19. doi: 10.1074/mcp.M114.042242. Epub 2014 Oct 28.

5.

Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia.

Datta A, Qian J, Chong R, Kalaria RN, Francis P, Lai MK, Chen CP, Sze SK.

J Proteomics. 2014 Mar 17;99:54-67. doi: 10.1016/j.jprot.2014.01.011. Epub 2014 Jan 19.

6.

Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.

Keshishian H, Burgess MW, Gillette MA, Mertins P, Clauser KR, Mani DR, Kuhn EW, Farrell LA, Gerszten RE, Carr SA.

Mol Cell Proteomics. 2015 Sep;14(9):2375-93. doi: 10.1074/mcp.M114.046813. Epub 2015 Feb 27.

PMID:
25724909
7.

Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin.

Kristensen LP, Larsen MR, Mickley H, Saaby L, Diederichsen AC, Lambrechtsen J, Rasmussen LM, Overgaard M.

J Proteomics. 2014 Apr 14;101:141-53. doi: 10.1016/j.jprot.2013.12.011. Epub 2013 Dec 22.

PMID:
24369271
8.

Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis.

Carlén LM, Sánchez F, Bergman AC, Becker S, Hirschberg D, Franzén B, Coffey J, Jörnvall H, Auer G, Alaiya AA, Ståhle M.

J Invest Dermatol. 2005 Jan;124(1):63-9.

9.

Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.

van Swelm RP, Laarakkers CM, Kooijmans-Otero M, de Jong EM, Masereeuw R, Russel FG.

Toxicol Lett. 2013 Aug 29;221(3):219-24. doi: 10.1016/j.toxlet.2013.06.234. Epub 2013 Jul 3.

PMID:
23830989
10.

Variability assessment of (15)N metabolic labeling-based proteomics workflow in mouse plasma and brain.

Filiou MD, Soukupova M, Rewerts C, Webhofer C, Turck CW, Maccarrone G.

Mol Biosyst. 2015 Jun;11(6):1536-42. doi: 10.1039/c4mb00702f.

PMID:
25782008
11.

Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers.

Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V.

Clin Proteomics. 2015 Jan 13;12(1):1. doi: 10.1186/1559-0275-12-1. eCollection 2015.

12.

Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology.

Datta A, Akatsu H, Heese K, Sze SK.

J Proteomics. 2013 Oct 8;91:556-68. doi: 10.1016/j.jprot.2013.08.017. Epub 2013 Sep 2.

PMID:
24007662
13.

Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.

de Wit M, Kant H, Piersma SR, Pham TV, Mongera S, van Berkel MP, Boven E, Pontén F, Meijer GA, Jimenez CR, Fijneman RJ.

J Proteomics. 2014 Mar 17;99:26-39. doi: 10.1016/j.jprot.2014.01.001. Epub 2014 Jan 10.

PMID:
24418523
14.

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

Whiteaker JR, Zhang H, Zhao L, Wang P, Kelly-Spratt KS, Ivey RG, Piening BD, Feng LC, Kasarda E, Gurley KE, Eng JK, Chodosh LA, Kemp CJ, McIntosh MW, Paulovich AG.

J Proteome Res. 2007 Oct;6(10):3962-75. Epub 2007 Aug 21.

PMID:
17711321
15.
16.

Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.

Kim PY, Tan O, Diakiw SM, Carter D, Sekerye EO, Wasinger VC, Liu T, Kavallaris M, Norris MD, Haber M, Chesler L, Dolnikov A, Trahair TN, Cheung NK, Marshall GM, Cheung BB.

J Proteomics. 2014 Jan 16;96:1-12. doi: 10.1016/j.jprot.2013.10.032. Epub 2013 Nov 4.

17.

Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin.

Ryu J, Park SG, Park BC, Choe M, Lee KS, Cho JW.

Int J Mol Med. 2011 Nov;28(5):785-92. doi: 10.3892/ijmm.2011.757. Epub 2011 Jul 25.

PMID:
21805023
18.

Serum proteomics in multiple sclerosis disease progression.

Tremlett H, Dai DL, Hollander Z, Kapanen A, Aziz T, Wilson-McManus JE, Tebbutt SJ, Borchers CH, Oger J, Cohen Freue GV.

J Proteomics. 2015 Apr 6;118:2-11. doi: 10.1016/j.jprot.2015.02.018. Epub 2015 Mar 6.

PMID:
25753122
19.

Targeted mass spectrometry approaches for protein biomarker verification.

Meng Z, Veenstra TD.

J Proteomics. 2011 Nov 18;74(12):2650-9. doi: 10.1016/j.jprot.2011.04.011. Epub 2011 Apr 21. Review.

PMID:
21540133
20.

Application of systems biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation.

Pisitkun T, Gandolfo MT, Das S, Knepper MA, Bagnasco SM.

Proteomics Clin Appl. 2012 Jun;6(5-6):268-78. doi: 10.1002/prca.201100108.

Items per page

Supplemental Content

Write to the Help Desk